Journal of Cancer Epidemiology / 2013 / Article / Tab 3

Research Article

Cancer Incidence and Mortality in a Cohort of US Blood Donors: A 20-Year Study

Table 3

Standardized incidence ratio (SIR) by sex and cancer site, allogeneic blood donors with more than one year of followup, Blood Centers of the Pacific, 1991–2009 ( = 54,982).

SIR 95% CI

Males
 Oral cavity and pharynx1.190.921.52
 Digestive1.241.101.38
 Respiratory0.930.791.08
 Skin2.191.892.53
 Male genital2.482.322.63
 Urinary1.150.971.37
 Brain and nervous1.551.112.10
 Endocrine0.780.471.21
 Lymphoma1.421.181.69
 Myeloma2.111.452.96
 Leukemia2.141.702.66
 Other1.451.161.78
Females
 Oral cavity and pharynx1.010.601.60
 Digestive1.671.451.90
 Respiratory1.481.251.74
 Skin1.771.482.11
 Breast1.791.661.92
 Female genital1.501.321.70
 Urinary1.160.841.55
 Brain and nervous1.591.052.31
 Endocrine0.910.701.16
 Lymphoma1.721.392.12
 Myeloma1.791.022.90
 Leukemia1.330.881.92
 Other1.681.232.24

SIR was calculated using nine SEER registries age-adjusted, sex-, and age-specific incidence rates for years 1992–2009.
Other includes: mesothelioma, Kaposi sarcoma, eye & orbit, bone, soft tissue, miscellaneous (SEER site recode ICD-O-3 definition).